Real-world treatment patterns and clinical outcomes of metastatic renal cell carcinoma patients post immune-oncology (IO) and vascular endothelial growth factor (VEGF) receptor targeted therapies Meeting Abstract
| Authors: | Shah, N.; Sura, S.; Shinde, R.; Wentworth, C.; Conkling, P.; Bupathi, M.; Perini, R.; Vickery, D.; Motzer, R. |
| Abstract Title: | Real-world treatment patterns and clinical outcomes of metastatic renal cell carcinoma patients post immune-oncology (IO) and vascular endothelial growth factor (VEGF) receptor targeted therapies |
| Meeting Title: | 6th Kidney Cancer Research Summit (KCRS 2024) |
| Keywords: | tyrosine kinase; inhibitors; metastatic renal cell carcinoma; clinical outcomes; treatment patterns; immune-oncology |
| Journal Title: | The Oncologist |
| Volume: | 29 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Jul 11-12 |
| Meeting Location: | Boston, MA |
| ISSN: | 1083-7159 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-09-01 |
| Start Page: | S22 |
| End Page: | S23 |
| Language: | English |
| ACCESSION: | WOS:001289325400038 |
| DOI: | 10.1093/oncolo/oyae181.037 |
| PROVIDER: | wos |
| PMCID: | PMC11301876 |
| Notes: | Meeting Abstract: 36 -- Abstract citation ID: oyae181.037 -- Meeting also took place virtually -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
